Stock Market & Financial Investment News

News Breaks January 11, 2013 06:43 EDT DNDN Dendreon upgraded to Outperform from Market Perform at Bernstein Bernstein upgraded Dendreon based on favorable urologists feedback that indicates increasing Provenge use and reduced expectations. Price target raised to $10 from $7. News For DNDN From The Last 14 Days Check below for free stories on DNDN the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 10, 2013 10:00 EDT DNDN On The Fly: Analyst Downgrade Summary Subscribe for More Information 09:38 EDT DNDN Active equity option families trading Subscribe for More Information 09:21 EDT DNDN On The Fly: Pre-market Movers Subscribe for More Information 07:55 EDT DNDN Dendreon may generate near-term trading opportunity, says RW Baird Subscribe for More Information 07:44 EDT DNDN Dendreon price target lowered to $1 from $5 at BofA/Merrill Subscribe for More Information 07:40 EDT DNDN Dendreon price target lowered to $6.50 from $9 at Bernstein Subscribe for More Information 05:51 EDT DNDN Dendreon downgraded to Sell from Neutral at Citigroup Subscribe for More Information May 9, 2013 14:15 EDT DNDN Dendreon downgraded to Sell from Neutral at Roth Capital Subscribe for More Information 13:32 EDT DNDN Dendreon downgraded to Sell from Hold at Stifel Subscribe for More Information 12:35 EDT DNDN On The Fly: Midday Wrap Subscribe for More Information 10:56 EDT DNDN Dendreon price target lowered to $3 from $4 at Maxim Subscribe for More Information 08:42 EDT DNDN Dendreon reports Q1 EPS (48c), consensus (48c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.